Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

PRODUCT CLI EUROIMMUN

Compact random access analyser

, 26 August 2020/in Product News /by 3wmedia

The RA Analyzer 10 is a compact random access device which provides fully automated processing of chemiluminescence immunoassays (ChLIA) for autoimmune and infection diagnostics as well as antigen detection. It is ideal for use in small- to medium-sized laboratories, or to complement high-throughput-devices in large laboratories.
The device allows continuous loading, also as part of a laboratory track system, ensuring that every sample is processed with minimal effort as a single determination. Up to 85 results can be obtained per hour. EUROIMMUN ChLIA technology offers short reaction times, with first results in just 25 minutes. Test- and lot-specific information, including stored standard curves, is imported by means of RFID codes, enabling error-free and convenient loading, along with efficient and secure test evaluation. Automatic identification of samples and reagents by means of barcodes ensures complete traceability. The system offers preferential processing of emergency samples (STAT), giving laboratories unparalleled flexibility in their laboratory routine.
New CE-marked EUROIMMUN ChLIA for use on the RA Analyzer 10 are available for detection of antibodies against Borrelia (IgG, IgM) Epstein-Barr virus (EBV-CA IgG, IgM; EBNA IgG), proteinase 3 (PR3, IgG) and phospholipase A2 receptor (PLA2R, IgG). Further ChLIA for detection of antibodies against tissue transglutaminase (tTG, IgA), CCP (IgG), myeloperoxidase (MPO, IgG), parvovirus B19 (IgG, IgM), HSV-1 (IgG) and HSV-2 (IgG), as well as calprotectin and biomarkers in Alzheimer’s disease will be available soon. Assays for many other parameters are under development.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_CLI_EUROIMMUN.jpg 576 751 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:38Compact random access analyser
C443 SIEMENS Hemoglobin A1c Test

Hemoglobin A1c test available on Atellica

, 26 August 2020/in Product News /by 3wmedia

Siemens Healthineers recently announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes. The International Diabetes Federation projects 642 million people worldwide will have diabetes by 2040 because of leading factors such as higher levels of urbanization, aging populations, and the growing adoption of more sedentary lifestyles which leads to insufficient physical activity, greater rates of obesity and a higher intake of unhealthy foods. When diagnosed, treated and monitored regularly, diabetes is manageable and, in some cases, reversible. Left untreated, however, blood sugar can rise to dangerous levels and lead to kidney damage and other irreversible health consequences. As diabetes awareness increases and screening for the chronic disease rises, testing options for the clinical laboratory are evolving both in sophistication and practicality. The Siemens Healthineers Atellica CH Enzymatic Hemoglobin A1c meets new standards of testing and offers laboratories improved performance – both precision and accuracy – over leading  alternative methodologies. Instruments with higher throughput capabilities offer laboratories the ability to run a greater volume of tests and produce patient results more quickly, thus improving patient satisfaction. Laboratories are seeking HbA1c assays that can be integrated onto chemistry testing platforms and that provide the accurate and precise results patients deserve. The new Atellica CH Enzymatic Hemoglobin A1c Assay offers these capabilities.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C443_SIEMENS_Hemoglobin_A1c_Test.jpg 450 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:47Hemoglobin A1c test available on Atellica
PRODUCT SIEMENS 2

Siemens Healthineers releases free eBook on coagulation testing protocols for COVID-19 patients

, 26 August 2020/in Corona News, Product News /by 3wmedia

Siemens Healthineers has a released an informative eBook titled “Coagulation abnormalities in COVID-19 patients – current testing and treatment protocols” to provide quick access to coagulation testing and treatment recommendations.
The eBook can be downloaded for free from their website: https://bit.ly/2CcpB5I
Because coagulation tests are important in the management of COVID-19 patients, the company has compiled an eBook for quick access to:

  • Thrombosis risk factors
  • An ISTH-recommended coagulation testing algorithm
  • Leading recommendations for anticoagulation treatment
  • Relevant parameters for patient monitoring

The eBook provides an overview of COVID-19 and thrombosis; it looks at laboratory testing in the identification of coagulation abnormalities in COVID-19 patients; and provides information on the treatment of coagulation abnormalities in COVID-19 patients.
Authors of the eBook write that while it’s not unusual for infections to raise the risk of clotting, the COVID-19 virus is associated with an unprecedented range of clotting-related disorders in affected patients. “From benign skin lesions on the feet to life-threatening thrombotic events, the COVID-19 virus has demonstrated a strikingly high prevalence of deadly blood clots. Studies show that about 25% and even up to 70% of critically ill patients have confirmed venous thromboembolism or pulmonary embolism. Another study found that approximately 70% of COVID-19 patients who died had disseminated intravascular coagulation.”
They add that Siemens Healthineers’s coagulation tests play an important role in the diagnosis, treatment, and management of coagulation abnormalities in COVID-19 patients and point out that the company has changed their production model to produce these assays at a higher volume than ever before.
“We are proud to support you in the fight against COVID-19. Behind every healthcare professional there are 53,000 Healthineers,” Siemens Healthineers says.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_SIEMENS_2.jpg 417 692 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:32Siemens Healthineers releases free eBook on coagulation testing protocols for COVID-19 patients
Thermo General Purpose Pro Centrifuge Series

Centrifuge with full colour touchscreen

, 26 August 2020/in Product News /by 3wmedia

Featuring an ergonomically enhanced, novel industrial design complemented by a wide range of rotors, the Thermo Scientific general purpose Pro Centrifuge Series has been developed to deliver a safe and regulatory-compliant benchtop separation solution to meet an array of application needs, from clinical protocols and cell culture procedures to microplate processing. The series has been equipped with an advanced touchscreen interface that gives users easy access to prestored protocols, temperature control and system health checks to improve productivity and reduce time spent performing manual maintenance. The general purpose Pro Centrifuge Series provides scientists with: a unique glass touchscreen that facilitates a simpler user interface for immediate, effortless workflow and operation monitoring, and easy cleaning; an ergonomically enhanced industrial design that enables the quick and safe change of any of its 19 rotor types in just three seconds through its Auto-Lock rotor exchange function; superior sample capacity, performance and bio-containment through its Fiberlite carbon fibre rotors and ClickSeal biocontainment lids; a compact separation solution fea-turing connectivity-ready technology, while optimizing benchtop space. The ge-neral purpose Pro Centrifuge Series meets global compliance standards and includes the Thermo Scientific Sorvall, Thermo Scientific Multifuge and Thermo Scientific Megafuge configurations, which can be easily configured with a selection of rotors to address a range of application needs.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/Thermo_General_Purpose_Pro_Centrifuge_Series.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:43Centrifuge with full colour touchscreen
C439 STAGO ST Genesia

Thrombin generation now available in laboratories

, 26 August 2020/in Product News /by 3wmedia

The new ST Genesia analyser is designed to automate and standardize results for thrombin generation. For laboratories, this is a significant step forward for assisting with assessment of thrombotic and hemorrhagic risks in patients.
ST Genesia is an automated analyser, based on the same principles as the CAT system, which measures thrombin generation. Designed to support clinical applications in the lab, the key difference between systems is that CAT’s main purpose is for research and development.
ST Genesia aims at standardizing and automating the thrombin generation test in order to make it widely accessible and available for use in in-vitro diagnostics (IVD). ST Genesia is designed to add to the information usually provided by routine tests (TP, TCA, etc.) or specialized tests (Anti-Xa, ECA) and offer an improved assessment of thrombotic and hemorrhagic risks.
A range of reagents specifically developed for ST Genesia is available including STG-ThromboScreen for thrombin generation assessment in patients who are likely to suffer from thrombophilia; STG-BleedScreen for thrombin generation assessment in patients with bleeding risk, such as hemophiliacs; STG-DrugScreen for assessment of the effect of anticoagulants on treated patients, which could be useful for people at risk of drug accumulation (impaired renal function, people over 75, etc.).

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C439_STAGO_ST_Genesia.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:50Thrombin generation now available in laboratories
PRODUCT NOVA BIOMEDICAL

Nova Biomedical launches Stat EMS Basic in CE Mark countries

, 26 August 2020/in Product News /by 3wmedia

Nova Biomedical has launched their Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Stat EMS Basic is a smaller, non-connectivity version of Nova’s connectivity-capable Stat EMS system with the same test menu. Stat EMS Basic combines battery-operated StatStrip Xpress2 meters in a new, lightweight soft case that easily fits in a medic’s bag while holding all system components: meters, test strips, controls, and lancets. Test strips and controls require no refrigeration, making testing convenient and economical.
Specifically designed for ambulance, prehospital, and emergency use, Stat EMS Basic provides an important test menu and rapid results to aid with patient assessment and allow for faster, more effective emergency treatment. Stat EMS Basic also assists with rapid triage and determining the appropriate transport site for patients who have trauma, sepsis, anemia, acute coronary syndrome, or other critical illnesses.
Stat EMS Basic meters are easy to use; there is no calibration or coding and the testing procedure is as simple as fingerstick glucose testing performed by people with diabetes. Tiny capillary samples eliminate the need for venipuncture, saving time and reducing costs.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_NOVA_BIOMEDICAL.jpg 997 847 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:35Nova Biomedical launches Stat EMS Basic in CE Mark countries
DIASOURCE CLI OCT 200x200 Visuels 5piliers Antibodies

Antibodies for IVD applications

, 26 August 2020/in Product News /by 3wmedia

Monoclonal antibodies (mAb) are important components of CE-marked IVD reagents used in diagnosis of diseases and follow-up of treatment. DIAsource Immunoassays, a BioVendor group company, recently announced the launch of 13 new antibodies for IVD applications: Adiponectin, FABP4, COMP, NT-ProANP, Uromodulin, Soluble Transferrin Receptor, Placental Protein 13, Cathepsin K and Procalcitonin antibodies are now available and offered to the IVD providers for development of Immunoassays. This follows the launches of novel Vitamin D conjugates, Vitamin D dissociation buffers, and antibodies against ACTH, PTH, IGF-1, Testosterone and Progesterone. All these antibodies were developed with special focus on sensitivity, selectivity and stability to ensure long-term supply. They are produced and fully automatically purified under strict ISO 9001 – ISO 13485 conditions. Products are available in purified unconjugated format. Large scale productions can be guaranteed in state-of-the-art facilities. DIAsource is continuously expanding its product portfolio with niche, high valued parameters and these new launches consolidate its actual position on the market, with an enlarged portfolio of proven and performing antibodies for IVD providers.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/DIASOURCE_CLI_OCT_200x200_Visuels_5piliers_Antibodies.jpg 800 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:45Antibodies for IVD applications
Randox QC Webvertorial CLI April 2019 IMAGE

Molecular IQC and EQA for infectious disease testing

, 26 August 2020/in Product News /by 3wmedia

Designed to meet the demands of today’s molecular diagnostics laboratory and laboratories carrying out nucleic acid testing, our range of Molecular IQC and EQA comprises hundreds of characterized viral, bacterial and fungal targets. These targets cover a wide range of transplant associated diseases, respiratory diseases, blood borne viruses, sexually transmitted infections, gastro-intestinal diseases and central nervous system diseases amongst others ensuring our molecular IQC and EQA range covers the full laboratory portfolio. Our samples are manufactured using only the highest quality material and the availability of whole pathogen samples ensures the performance of the patient sample is mimicked throughout.
https://www.randox.com/product-spotlight-molecular/
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/Randox_QC_-_Webvertorial_-_CLI_-_April_2019_-_IMAGE.png 730 730 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:53Molecular IQC and EQA for infectious disease testing
CLI 200616 doc image tubular markers HR

Retinol-Binding Protein (RBP), and other urinary low molecular weight protein assays, as markers of renal tubular function

, 26 August 2020/in Product News /by 3wmedia

TRIMERO Diagnostics offers IVD CE urinary assays of low molecular weight proteins, by nephelometry or turbidimetry, for the assessment of renal tubular function:

  • Retinol-Binding Protein (RBP)
  • Alpha-1 Microglobulin (α1μ)
  • Cystatin C (CysC)
  • Beta-2 Microglobulin (β2μ)
  • KLoneus® Kappa and Lambda Free Light Chains (FLC)
  • Kappa and Lambda (B&F) Light Chains

These assays, specifically designed for their use on urine samples, are available for the nephelometers and the most popular clinical chemistry analyzers present in the market.
Other TRIMERO’s available nephelometric and turbidimetric assays include:
Serum Amyloid A (SAA), IgD Immunoglobulins, Soluble Transferrin Receptor (sTfR), Hemopexin, Complement C1q, Complement C5, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/CLI_200616_doc_image_tubular-markers-_HR_.jpg 883 723 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:30Retinol-Binding Protein (RBP), and other urinary low molecular weight protein assays, as markers of renal tubular function
PRODUCT CLI RANDOX

Randox unveils new coronavirus test at Medlab Middle East 2020

, 26 August 2020/in Product News /by 3wmedia

A ground-breaking test for the potentially fatal 2019-nCoV strain of coronavirus, is in the final stages of development at global health diagnostics company Randox Laboratories. The soon-to-be-launched test, developed on Randox’s patented Biochip Technology, will be available for immediate SARS-COV-2 testing, but an additional enhanced multiplex array will also include tests for other respiratory viruses which can display the same symptoms. The new enhanced Biochip will therefore allow clinicians to quickly and efficiently differentiate between potentially lethal and non-lethal infections.
Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented; “Current technologies for the diagnosis of coronavirus are designed simply to detect the presence or lack of 2019-nCoV, and therefore neglect to differentiate between this strain and other respiratory infections. Whilst we’re very quickly developing an efficient novel test for this new strain of coronavirus, we are therefore also working on an extended Viral Respiratory Infection Array that will test simultaneously for 2019-nCoV and a range of other viruses. This will eliminate the need for multiple back-and-forth tests before the root cause of symptoms is found, and empower clinicians to make fast and informed decisions.” The test will be available for the Point of Care analyser, the Vivalytic, within 3 hours, and within 5 hours on the Randox Evidence Investigator. Benefits of the new Randox SARS-COV-2 test

  • Quick Turnaround Times (3 hours on Vivalytic and 5 hours on Evidence Investigator)
  • Multiplex array differentiates between mild and serious infection
  • Automated and Semi-Automated options available

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/PRODUCT_CLI_RANDOX.jpg 609 1000 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:16:522021-01-08 11:20:38Randox unveils new coronavirus test at Medlab Middle East 2020
Page 148 of 149«‹146147148149›
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription